Nicklas, 2019 - Google Patents
Exploring interactions between the parasite plasma membrane and the parasite vacuolar membrane of Plasmodium falciparumNicklas, 2019
View PDF- Document ID
- 16729391713307802037
- Author
- Nicklas S
- Publication year
External Links
Snippet
Malaria poses a large health and economical threat to 40% of the world's population. Treatment and prophylaxis with antimalarials remain a mainstay to control malaria. However, drug resistance remains a constant threat to these efforts. It is hoped that with the …
- 244000045947 parasites 0 title abstract description 591
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Botté et al. | Plasmodium falciparum apicoplast drugs: targets or off-targets? | |
| Dash et al. | Gametogenesis in Plasmodium: delving deeper to connect the dots | |
| Légaré et al. | Drug resistance in Leishmania | |
| Mukherjee et al. | A phosphoinositide-binding protein acts in the trafficking pathway of hemoglobin in the malaria parasite Plasmodium falciparum | |
| Zheng et al. | ATG ubiquitination is required for circumsporozoite protein to subvert host innate immunity against rodent malaria liver stage | |
| Nicklas | Exploring interactions between the parasite plasma membrane and the parasite vacuolar membrane of Plasmodium falciparum | |
| Tarique et al. | Drug Targets for Plasmodium Falciparum: Historic to Future Perspectives | |
| Chawla | A Forward Genetic Screen Identifies Genes Involved in Gametocyte Development of the Human Malaria Parasite Plasmodium falciparum. | |
| Walker | The Study of Autophagy in Plasmodium falciparum | |
| Carpenter | The influence of genetic background on drug resistance in the malaria parasite Plasmodium falciparum | |
| AU780085B2 (en) | Use of hydroxydiphenyl ether class of chemicals, as exemplified by triclosan, as an antimalarial and identification of fatty acid synthesis as its target | |
| Edgar | Characterising the aminopeptidases of Plasmodium falciparum as potential drug targets | |
| Posfai | Elucidating Plasmodium Liver Stage Biology Through Transcriptomic Approaches | |
| Marreiros | A Metabolic Arms Race Between Host and Parasite: Amino Acid Sensing and Response in Plasmodium | |
| Fagbami | Chemogenomic Interrogation of the Adaptive Proline Response to Halofuginone in Plasmodium falciparum | |
| Clements | Molecular requirements for morphogenesis in Plasmodium falciparum, the human malaria parasite | |
| Maré | Towards Genetic Interrogation of Putative Amino Acid Transporters in Plasmodium Falciparum Parasites | |
| Pershing | Genetic exploration of the ATP synthase complex in Plasmodium falciparum | |
| Da Rocha | Chemical and genetic interrogation of Plasmodium falciparum mitochondrial pyruvate carriers | |
| Hayward | Elucidating and Exploiting the Mitochondrial Electron Transport Chain of Apicomplexan Parasites | |
| Babij | Understanding collateral sensitivity in the malaria parasite | |
| Schnider | Parasite-host interactions during the blood and liver stage of rodent malaria parasites | |
| Berneburg | NADPH-producing Enzymes from the Pentose Phosphate Pathway of Plasmodium and Leishmania as Targets for New Anti-infective Agents | |
| Butler | An Exported Malaria Protein Regulates Glucose Uptake During Intraerythrocytic Infection | |
| Sabitzki | Identification and functional analysis of proteins involved in host cell cytosol uptake of the human malaria parasite Plasmodium falciparum |